Item 7.01 Regulation FD Disclosure

On January 8, 2013, representatives of Neuralstem, Inc. (the "Company") presented at the Sixth Annual OneMedForum in San Francisco, California. It is also anticipated that several investor presentations will be made during the next few weeks. Filed herewith as Exhibit 99.01 are the slides that were presented at such conference and will be used in the upcoming investor presentations.

The information contained in this Current Report on Form 8-K and the exhibits attached hereto shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall such information or such exhibits be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing. The information set forth in or exhibits to this Form 8-K shall not be deemed an admission as to the materiality of any information in this report that is required to be disclosed solely to satisfy the requirements of Regulation FD.

Item 9.01 Financial Statement and Exhibits.

Exhibit Number Description

99.01 Slides presented at conference on January 8, 2013